Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Aims:
1. To pilot an randomized, controlled trial (RCT) to assess the effectiveness of the
commonly prescribed medications in UK general practice for IBS: mebeverine
(anti-spasmodic) and methylcellulose (bulking-agent) and of the patient CBT based
self-management website.
2. To assess the level of support needed for patients using the patient CBT based
self-management website for IBS (i.e., initial 30 minute telephone support session with
a nurse and email support or not).
Phase:
Phase 4
Details
Lead Sponsor:
Hazel Everitt
Collaborator:
National Institute for Health Research, United Kingdom